| 1 |
34264566 | The combination therapy of targeting both paclitaxel and Dendrophthoe pentandra leaves extract nanoparticles for improvement breast cancer treatment efficacy by reducing TUBB3 and MAP4 expressions. | 2021 Jul 15 |
2 |
| 2 |
32829374 | Octreotide-Paclitaxel Conjugate Reverses Paclitaxel Resistance by p38 Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in A2780/Taxol Human Ovarian Cancer Cells. | 2020 Aug 23 |
1 |
| 3 |
30431082 | ERp57‑small interfering RNA silencing can enhance the sensitivity of drug‑resistant human ovarian cancer cells to paclitaxel. | 2019 Jan |
1 |
| 4 |
30643929 | Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study. | 2019 Apr |
1 |
| 5 |
30711942 | Class III β-tubulin Expression in Colorectal Neoplasms Is a Potential Predictive Biomarker for Paclitaxel Response. | 2019 Feb |
3 |
| 6 |
29439899 | High expression of class III β-tubulin has no impact on functional cancer cell growth inhibition of a series of key vinblastine analogs. | 2018 Mar 1 |
1 |
| 7 |
29491095 | Expression of Class III Beta-tubulin Predicts Prognosis in Patients with Cisplatin-resistant Bladder Cancer Receiving Paclitaxel-based Second-line Chemotherapy. | 2018 Mar |
4 |
| 8 |
29069726 | TUBB3 overexpression has a negligible effect on the sensitivity to taxol in cultured cell lines. | 2017 Sep 22 |
8 |
| 9 |
27284014 | Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation. | 2016 Jun 7 |
6 |
| 10 |
28003747 | MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell. | 2016 |
2 |
| 11 |
25964544 | Class III Beta-tubulin Expression in Non-small Cell Lung Cancer: A Predictive Factor for Paclitaxel Response. | 2015 May |
4 |
| 12 |
24005572 | Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxel. | 2014 Jan |
5 |
| 13 |
24220933 | Longitudinal assessment of TUBB3 expression in non-small cell lung cancer patients. | 2014 Jan |
1 |
| 14 |
24722794 | The relationships between the chemosensitivity of human gastric cancer to paclitaxel and the expressions of class III β-tubulin, MAPT, and survivin. | 2014 May |
4 |
| 15 |
25016949 | Combination of microtubule associated protein-tau and β-tubulin III predicts chemosensitivity of paclitaxel in patients with advanced gastric cancer. | 2014 Sep |
4 |
| 16 |
25107571 | Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum-paclitaxel chemotherapy. | 2014 Oct |
3 |
| 17 |
25211704 | Identification of the first inhibitor of the GBP1:PIM1 interaction. Implications for the development of a new class of anticancer agents against paclitaxel resistant cancer cells. | 2014 Oct 9 |
1 |
| 18 |
23259428 | Class III b-tubulin overexpression in gynecologic tumors: implications for the choice of microtubule targeted agents? | 2013 Jan |
1 |
| 19 |
23364970 | Blockade of VEGFR-1 and VEGFR-2 enhances paclitaxel sensitivity in gastric cancer cells. | 2013 Mar 1 |
5 |
| 20 |
23583215 | Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone. | 2013 Jul |
3 |
| 21 |
23585021 | Tubulin-β-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones. | 2013 Jul 15 |
3 |
| 22 |
21471564 | Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials. | 2012 Jan |
2 |
| 23 |
22306125 | Association between class III β-tubulin expression and response to paclitaxel/vinorebine-based chemotherapy for non-small cell lung cancer: a meta-analysis. | 2012 Jul |
6 |
| 24 |
22684772 | Clinical implications of REST and TUBB3 in ovarian cancer and its relationship to paclitaxel resistance. | 2012 Oct |
3 |
| 25 |
22766748 | Serum levels of TUBB3 correlate with clinical outcome in Chinese patients with advanced gastric cancer receiving first-line paclitaxel plus capecitabine. | 2012 Dec |
4 |
| 26 |
23028798 | Overexpression of class III beta tubulin and amplified HER2 gene predict good response to paclitaxel and trastuzumab therapy. | 2012 |
1 |
| 27 |
21634028 | Regulation of β-tubulin isotypes by micro-RNA 100 in MCF7 breast cancer cells. | 2011 Jun |
1 |
| 28 |
23358102 | Expressions of Thymidylate Synthase,Thymidine Phosphorylase, Class III β-tubulin, and Excision Repair Cross-complementing Group 1predict Response in Advanced Gastric Cancer Patients Receiving Capecitabine Plus Paclitaxel or Cisplatin. | 2011 Dec |
1 |
| 29 |
20029418 | Class III beta-tubulin expression and in vitro resistance to microtubule targeting agents. | 2010 Jan 19 |
1 |
| 30 |
20403547 | [Class III beta tubulin expression in nonsmall cell lung cancer]. | 2010 Apr |
1 |
| 31 |
18977553 | Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel. | 2009 Jun |
2 |
| 32 |
19122647 | Loss of class III beta-tubulin induced by histone deacetylation is associated with chemosensitivity to paclitaxel in malignant melanoma cells. | 2009 Jun |
2 |
| 33 |
19287064 | Expression of class III beta-tubulin in colorectal carcinomas: an immunohistochemical study using TU-20 & TuJ-1 antibody. | 2009 Jan |
2 |
| 34 |
19714814 | Comparative proteomic analysis of paclitaxel sensitive A2780 epithelial ovarian cancer cell line and its resistant counterpart A2780TC1 by 2D-DIGE: the role of ERp57. | 2009 Apr |
2 |
| 35 |
20021611 | Expression of ERCC1 and class IIIbeta tubulin for predicting effect of carboplatin/paclitaxel in patients with advanced inoperable non-small cell lung cancer. | 2009 Dec |
1 |
| 36 |
18237851 | Is class III beta-tubulin a predictive factor in patients receiving tubulin-binding agents? | 2008 Feb |
2 |
| 37 |
18317222 | Taxol resistance among the different histological subtypes of ovarian cancer may be associated with the expression of class III beta-tubulin. | 2008 Apr |
4 |
| 38 |
18395930 | Expression of excision repair cross-complementation group 1 and class III beta-tubulin predict survival after chemotherapy for completely resected non-small cell lung cancer. | 2008 Oct |
2 |
| 39 |
18505052 | Protein abundance of class III beta-tubulin but not Delta2-alpha-tubulin or tau is related to paclitaxel response in carcinomas of unknown primary site. | 2008 Mar-Apr |
3 |
| 40 |
19074887 | Molecular mechanisms of patupilone resistance. | 2008 Dec 15 |
2 |
| 41 |
17021819 | Class III beta-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site. | 2007 Jun |
4 |
| 42 |
17285590 | Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulins. | 2007 May 15 |
3 |
| 43 |
17714470 | Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia. | 2007 Oct |
3 |
| 44 |
15671559 | Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. | 2005 Jan 1 |
3 |
| 45 |
15781655 | The seco-taxane IDN5390 is able to target class III beta-tubulin and to overcome paclitaxel resistance. | 2005 Mar 15 |
5 |
| 46 |
16373715 | Class III beta-tubulin expression in tumor cells predicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel. | 2005 Dec |
4 |
| 47 |
10362110 | Antisense oligonucleotides to class III beta-tubulin sensitize drug-resistant cells to Taxol. | 1999 Jun |
2 |
| 48 |
8640766 | Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol). | 1996 Mar 1 |
1 |
| 49 |
8714689 | Effects of taxol on the polymerization and posttranslational modification of class III beta-tubulin in P19 embryonal carcinoma cells. | 1995 Sep-Oct |
5 |